Benjamin Charles is the founder of DiogenX. DiogenX has raised $35M in total funding. Latest round: Series A. Based in Marseille, France.
Benjamin Charles is a co-founder and chief executive officer of DiogenX, a French preclinical biotechnology company focused on pancreatic beta-cell regeneration for diabetes treatment. DiogenX was founded in December 2019 by Patrick Collombat, Benjamin Charles, and Jean-Pascal Tranié, and is based in Marseille with research laboratories in Nice.
Full founder directory · Investor directory · Company funding database · Fundraising library